The FDA regulates hyperbaric oxygen therapy products and recommends their use for selected conditions. Furthermore, Global corporations including the UHMS present rules for credentialing and supervision of HBOT.The cost and accessibility of hyperbaric oxygen therapy (HBOT) will vary considerably based upon the type of facility and its geographical